CFPB Rolls Out New Data Updates for Mortgage Registry Checks

Orrick logo

The mortgage world is kicking off the year with a notable update from the Consumer Financial Protection Bureau (CFPB). On January 15, the Bureau published an important notice in the Federal Register outlining proposed updates to the Nationwide Mortgage Licensing System and Registry (NMLS). If you’re a mortgage loan originator—or planning to become one—this is the kind of regulatory shift worth paying attention to.

What’s Changing—and Why It Matters

Expanded Use of Collected Data: Data will now explicitly support registry administration, background investigations, and identity verification. This also ensures compliance with DOJ and FBI requirements for criminal history checks.

More Detailed Categories of Records: The system will now collect additional data elements from mortgage loan originators, administrative users, and federal regulators—expanding oversight accuracy.

Updated Record Retention Rules: The retention schedule is getting a refresh to match the current approved system, keeping the process aligned with modern regulatory expectations.

Authorized Disclosure for Audits: The National Archives and Records Administration will now receive access for official records management inspections.

Alignment with OMB Standards: A series of non-substantive revisions will bring the system in line with the Office of Management and Budget’s recommended model.

What This Means for Mortgage Professionals

For current and aspiring mortgage loan originators, compliance continues to evolve—and staying informed is crucial. These updates refine how your professional data is handled, especially concerning background checks and federal oversight.

For students pursuing their MLO license through accredited real estate and mortgage education providers—such as Cameron Academy—understanding these regulatory shifts is essential. Today’s mortgage environment demands professionals who can navigate both lending knowledge and compliance obligations with confidence.

Want to Dive Deeper?

This update was originally highlighted by JD Supra and further explored by Orrick’s Infobytes team—both excellent resources for regulatory watchers.

Read the full coverage here:

JD Supra Article
Orrick Infobytes Source

Public comments on the proposed changes are open until February 17—so if this update affects your day‑to‑day, now is the perfect moment to make your voice heard.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

U.S. Precision Medicine Market Set to Triple by 2033

The U.S. precision medicine market is projected to expand from USD 24.95 billion in 2023 to a staggering USD 76.12 billion by 2033, driven by a compound annual growth rate (CAGR) of 11.80% from 2024 to 2033.

By |January 1, 2025|Categories: Article, Healthcare, Market Trends|Tags: , |0 Comments

The Future of Cybersecurity: Resilience’s Predictions for 2025

"As we edge closer to 2025, experts from the cybersecurity firm Resilience have shared their insights, shedding light on the challenges and transformations that lie ahead."

By |January 1, 2025|Categories: Article, Cybersecurity, Insurance Industry|Tags: |0 Comments

Revolutionizing Healthcare: NHS Trials AI Tool for Early Diabetes Detection

In an unprecedented leap for preventive medicine, the National Health Service (NHS) in England is poised to trial Aire-DM, a groundbreaking AI tool designed to predict the risk of type 2 diabetes a remarkable 13 years before its onset.

Revolutionizing Skin Cancer Diagnosis with AI: Efficacy and Future Prospects

In a groundbreaking study, AI shows potential to match or surpass specialists in diagnosing skin cancer, challenging traditional dermatological practices.

By |December 31, 2024|Categories: Article, Artificial Intelligence, Healthcare|Tags: |0 Comments

The Dawn of Personalized Medicine: AI’s Transformative Role in Healthcare

In a world where the promise of personalized medicine is finally being realized, Erez Meltzer, CEO & Board Member of Nanox, stands at the forefront of this revolution.

DeFi: Revolutionizing the Financial Landscape

In a compelling exploration of the financial landscape, Himanshu Kumar, CEO of AMBCrypto, delves into the transformative potential of Decentralized Finance (DeFi) and its implications for traditional banking. Highlighting DeFi's revolutionary approach, Kumar discusses how the democratization of financial services through blockchain technology is reshaping access, breaking down barriers, and challenging established institutions.

By |December 31, 2024|Categories: Article, Finance, Technology|Tags: , |0 Comments